Antiviral immunotropic agent for the treatment of acute respiratory viral infections

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11365216
APP PUB NO 20190322701A1
SERIAL NO

16221475

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The proposed methods of treatment pertain to medicine, in particular pharmacology, and concerns the application of a nasal medicinal composition containing hexapeptide tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine or its pharmaceutically acceptable salt for the treatment of acute respiratory viral infections (ARVIs), in particular those caused by the influenza virus.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • PVP LABS PTE. LTD

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chertorizhsky, Evgeny Alexandrovich Belkino Village, RU 4 0
Kleimenov, Aleksey Viktorovich Zhukov, RU 4 0
Ovchinnikov, Mikhail Vladimirovich Moscow, RU 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 21, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 21, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 21, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00